申请人:SmithKline Corporation
公开号:US04255422A1
公开(公告)日:1981-03-10
7,8-Dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines having a halo substituent at the 6-position have potent dopaminergic activity. The 6-chloro congeners are most active.
在6位有卤素取代基的7,8-二羟基-1-苯基-2,3,4,5-四氢-1H-3-苯并吡啶具有强大的多巴胺活性。其中,6-氯同系物活性最强。